DGX financials
Quest Diagnostics (DGX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
DGX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $11.04B | $3.52B | $1.60B | $992.00M | 8.75 |
| 2024 | $9.87B | $3.24B | $1.35B | $871.00M | 7.69 |
| 2023 | $9.25B | $3.07B | $1.26B | $854.00M | 7.52 |
| 2022 | $9.88B | $3.43B | $1.43B | $946.00M | 7.98 |
| 2021 | $10.79B | $4.21B | $2.38B | $2.00B | 15.53 |
| 2020 | $9.44B | $3.63B | $1.97B | $1.43B | 10.52 |
- DGX revenue was $11.04B in fiscal 2025, net income $992.00M.
Updated 2026-11-02 23:13 UTC